{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:53:56Z","timestamp":1792547636110,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78062-6","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T10:03:14Z","timestamp":1730455394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mechanism differences in the start time of sublingual immunotherapy in a mouse allergic airway inflammation model"],"prefix":"10.1038","volume":"14","author":[{"given":"Akira","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Koya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Naramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyo","family":"Ohashi-Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"78062_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nri2262","volume":"8","author":"ST Holgate","year":"2008","unstructured":"Holgate, S. T. & Polosa, R. Treatment strategies for allergy and asthma. Nat. Rev. Immunol. 8, 218\u2013230 (2008).","journal-title":"Nat. Rev. Immunol."},{"issue":"131\u2013138","key":"78062_CR2","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1016\/j.jaci.2009.10.035","volume":"125","author":"SR Durham","year":"2010","unstructured":"Durham, S. R. et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J. Allergy Clin. Immunol. 125(131\u2013138), e131-137 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0140-6736(06)69286-6","volume":"368","author":"S Illi","year":"2006","unstructured":"Illi, S. et al. Perennial allergen sensitisation early in life and chronic asthma in children: A birth cohort study. Lancet 368, 763\u2013770 (2006).","journal-title":"Lancet"},{"key":"78062_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jaci.2013.04.049","volume":"132","author":"PG Holt","year":"2013","unstructured":"Holt, P. G. et al. Prophylactic use of sublingual allergen immunotherapy in high-risk children: A pilot study. J. Allergy Clin. Immunol. 132, 991-993 e991 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jaci.2015.04.045","volume":"136","author":"Z Zolkipli","year":"2015","unstructured":"Zolkipli, Z. et al. Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood. J. Allergy Clin. Immunol. 136, 1541-1547 e1511 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/pai.12310","volume":"25","author":"Z Szepfalusi","year":"2014","unstructured":"Szepfalusi, Z. et al. Preventive sublingual immunotherapy in preschool children: First evidence for safety and pro-tolerogenic effects. Pediatr. Allergy Immunol. 25, 788\u2013795 (2014).","journal-title":"Pediatr. Allergy Immunol."},{"key":"78062_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa1414850","volume":"372","author":"G Du Toit","year":"2015","unstructured":"Du Toit, G. et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N. Engl. J. Med. 372, 803\u2013813 (2015).","journal-title":"N. Engl. J. Med."},{"key":"78062_CR8","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/all.13744","volume":"74","author":"C Alviani","year":"2019","unstructured":"Alviani, C. et al. Follow-up, 18 months off house dust mite immunotherapy, of a randomized controlled study on the primary prevention of atopy. Allergy 74, 1406\u20131408 (2019).","journal-title":"Allergy"},{"key":"78062_CR9","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.jaci.2020.01.048","volume":"145","author":"C Alviani","year":"2020","unstructured":"Alviani, C. et al. Primary prevention of asthma in high-risk children using HDM SLIT: Assessment at age 6 years. J. Allergy Clin. Immunol. 145, 1711\u20131713 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1398-9995.2006.01014.x","volume":"61","author":"B Winkler","year":"2006","unstructured":"Winkler, B. et al. The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice. Allergy 61, 173\u2013180 (2006).","journal-title":"Allergy"},{"key":"78062_CR11","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.jaci.2019.02.007","volume":"143","author":"E Haspeslagh","year":"2019","unstructured":"Haspeslagh, E. et al. Prophylactic allergen immunotherapy with Der p 2 prevents murine asthma by regulating lung GM-CSF. J. Allergy Clin. Immunol. 143, 2307-2311 e2305 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.alit.2020.08.002","volume":"69","author":"UC Kucuksezer","year":"2020","unstructured":"Kucuksezer, U. C. et al. Mechanisms of allergen-specific immunotherapy and allergen tolerance. Allergol. Int. 69, 549\u2013560 (2020).","journal-title":"Allergol. Int."},{"key":"78062_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jaci.2022.01.016","volume":"149","author":"MH Shamji","year":"2022","unstructured":"Shamji, M. H. et al. Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma. J. Allergy Clin. Immunol. 149, 791\u2013801 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR14","doi-asserted-by":"publisher","first-page":"763243","DOI":"10.3389\/fimmu.2021.763243","volume":"12","author":"S Musiol","year":"2021","unstructured":"Musiol, S. et al. TGF-beta1 drives inflammatory Th cell but not treg cell compartment upon allergen exposure. Front. Immunol. 12, 763243 (2021).","journal-title":"Front. Immunol."},{"key":"78062_CR15","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.jaci.2018.10.016","volume":"142","author":"P Bacher","year":"2018","unstructured":"Bacher, P. & Scheffold, A. The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy. J. Allergy Clin. Immunol. 142, 1697\u20131709 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR16","first-page":"139","volume":"38","author":"T Boonpiyathad","year":"2020","unstructured":"Boonpiyathad, T., Sozener, Z. C., Akdis, M. & Akdis, C. A. The role of Treg cell subsets in allergic disease. Asian Pac. J. Allergy Immunol. 38, 139\u2013149 (2020).","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"78062_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2013.12.1037","volume":"133","author":"A Syed","year":"2014","unstructured":"Syed, A. et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J. Allergy Clin. Immunol. 133, 500\u2013510 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/all.13479","volume":"74","author":"L Mondoulet","year":"2019","unstructured":"Mondoulet, L. et al. Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut-sensitized mice. Allergy 74, 152\u2013164 (2019).","journal-title":"Allergy"},{"key":"78062_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jaci.2010.08.030","volume":"126","author":"M Marogna","year":"2010","unstructured":"Marogna, M., Spadolini, I., Massolo, A., Canonica, G. W. & Passalacqua, G. Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study. J. Allergy Clin. Immunol. 126, 969\u2013975 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.alit.2014.07.001","volume":"64","author":"K Yamanaka","year":"2015","unstructured":"Yamanaka, K. et al. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects Sensitized to Japanese cedar pollen. Allergol. Int. 64, 54\u201359 (2015).","journal-title":"Allergol. Int."},{"issue":"1199\u20131206","key":"78062_CR21","first-page":"e1191","volume":"135","author":"M Westman","year":"2015","unstructured":"Westman, M. et al. Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence. J. Allergy Clin. Immunol. 135(1199\u20131206), e1191\u2013e1111 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR22","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jaci.2020.01.006","volume":"145","author":"M Westman","year":"2020","unstructured":"Westman, M. et al. Sensitization to grass pollen allergen molecules in a birth cohort-natural Phl p 4 as an early indicator of grass pollen allergy. J. Allergy Clin. Immunol. 145, 1174\u201311811176 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR23","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3389\/fimmu.2020.01368","volume":"11","author":"I Tulaeva","year":"2020","unstructured":"Tulaeva, I. et al. Preventive allergen-specific vaccination against allergy: Mission possible?. Front. Immunol. 11, 1368 (2020).","journal-title":"Front. Immunol."},{"key":"78062_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aba6087","author":"G Seumois","year":"2020","unstructured":"Seumois, G. et al. Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthma. Sci. Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aba6087 (2020).","journal-title":"Sci. Immunol."},{"key":"78062_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150634","author":"B Monian","year":"2022","unstructured":"Monian, B. et al. Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI150634 (2022).","journal-title":"J. Clin. Invest."},{"key":"78062_CR26","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.immuni.2021.08.014","volume":"54","author":"M Muschaweck","year":"2021","unstructured":"Muschaweck, M. et al. Cognate recognition of microbial antigens defines constricted CD4(+) T cell receptor repertoires in the inflamed colon. Immunity 54, 2565-2577 e2566 (2021).","journal-title":"Immunity"},{"key":"78062_CR27","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1084\/jem.178.6.2123","volume":"178","author":"H Secrist","year":"1993","unstructured":"Secrist, H., Chelen, C. J., Wen, Y., Marshall, J. D. & Umetsu, D. T. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J. Exp. Med. 178, 2123\u20132130 (1993).","journal-title":"J. Exp. Med."},{"key":"78062_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1046\/j.1365-2567.1996.506585.x","volume":"87","author":"H Akoum","year":"1996","unstructured":"Akoum, H. et al. Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes. Immunology 87, 593\u2013598 (1996).","journal-title":"Immunology"},{"key":"78062_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaci.2021.03.030","volume":"148","author":"MH Shamji","year":"2021","unstructured":"Shamji, M. H. et al. Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy. J. Allergy Clin. Immunol. 148, 1061-1071 e1011 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.alit.2016.05.012","volume":"66","author":"K Shima","year":"2017","unstructured":"Shima, K. et al. Effects of sublingual immunotherapy in a murine asthma model sensitized by intranasal administration of house dust mite extracts. Allergol. Int. 66, 89\u201396 (2017).","journal-title":"Allergol. Int."},{"issue":"Suppl 95","key":"78062_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1398-9995.2011.02631.x","volume":"66","author":"P Demoly","year":"2011","unstructured":"Demoly, P. & Calderon, M. A. Dosing and efficacy in specific immunotherapy. Allergy 66(Suppl 95), 38\u201340 (2011).","journal-title":"Allergy"},{"key":"78062_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13601-015-0088-1","volume":"5","author":"P Demoly","year":"2015","unstructured":"Demoly, P., Passalacqua, G., Calderon, M. A. & Yalaoui, T. Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose. Clin. Transl. Allergy 5, 44 (2015).","journal-title":"Clin. Transl. Allergy"},{"key":"78062_CR33","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.jaip.2022.01.046","volume":"10","author":"C Wongsa","year":"2022","unstructured":"Wongsa, C. et al. Efficacy and safety of house dust mite sublingual immunotherapy tablet in allergic asthma: A systematic review of randomized controlled trials. J. Allergy Clin. Immunol. Pract. 10, 1342\u201313551324 (2022).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"78062_CR34","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/all.15012","volume":"77","author":"A Heldner","year":"2022","unstructured":"Heldner, A. et al. Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy. Allergy 77, 907\u2013919 (2022).","journal-title":"Allergy"},{"key":"78062_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s42003-020-01466-3","volume":"3","author":"N Miyanaga","year":"2020","unstructured":"Miyanaga, N. et al. Essential role of submandibular lymph node dendritic cells in protective sublingual immunotherapy against murine allergy. Commun. Biol. 3, 742 (2020).","journal-title":"Commun. Biol."},{"key":"78062_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000446155","volume":"170","author":"S Hagner","year":"2016","unstructured":"Hagner, S. et al. House dust mite-specific sublingual immunotherapy prevents the development of allergic inflammation in a mouse model of experimental asthma. Int. Arch. Allergy Immunol. 170, 22\u201334 (2016).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"78062_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/ACI.0000000000000216","volume":"15","author":"E Wambre","year":"2015","unstructured":"Wambre, E. Effect of allergen-specific immunotherapy on CD4+ T cells. Curr. Opin. Allergy Clin. Immunol. 15, 581\u2013587 (2015).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"78062_CR38","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1111\/all.14896","volume":"76","author":"SH Wang","year":"2021","unstructured":"Wang, S. H. et al. An exhausted phenotype of T(H) 2 cells is primed by allergen exposure, but not reinforced by allergen-specific immunotherapy. Allergy 76, 2827\u20132839 (2021).","journal-title":"Allergy"},{"key":"78062_CR39","doi-asserted-by":"publisher","first-page":"152824","DOI":"10.1016\/j.imbio.2024.152824","volume":"229","author":"X Jie","year":"2024","unstructured":"Jie, X. et al. Increased inhibitory surface marker PD-1 expression in CD4(+)T cells and Th2(+)T cells in allergen-specific immunotherapy. Immunobiology 229, 152824 (2024).","journal-title":"Immunobiology"},{"key":"78062_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ebiom.2018.09.016","volume":"36","author":"UM Zissler","year":"2018","unstructured":"Zissler, U. M. et al. Early IL-10 producing B-cells and coinciding Th\/Tr17 shifts during three year grass-pollen AIT. EBioMedicine 36, 475\u2013488 (2018).","journal-title":"EBioMedicine"},{"key":"78062_CR41","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18, e3000410 (2020).","journal-title":"PLoS Biol."},{"key":"78062_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1165\/rcmb.2019-0325OC","volume":"63","author":"H Ueno","year":"2020","unstructured":"Ueno, H. et al. Cysteinyl leukotriene synthesis via phospholipase A2 group IV mediates exercise-induced bronchoconstriction and airway remodeling. Am. J. Respir. Cell Mol. Biol. 63, 57\u201366 (2020).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"78062_CR43","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jaci.2007.01.039","volume":"119","author":"T Koya","year":"2007","unstructured":"Koya, T. et al. IL-10-treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice. J. Allergy Clin. Immunol. 119, 1241\u20131250 (2007).","journal-title":"J. Allergy Clin. Immunol."},{"key":"78062_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1164\/rccm.200505-783OC","volume":"173","author":"T Koya","year":"2006","unstructured":"Koya, T. et al. Importance of myeloid dendritic cells in persistent airway disease after repeated allergen exposure. Am. J. Respir. Crit. Care Med. 173, 42\u201355 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"78062_CR45","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573-3587 e3529 (2021).","journal-title":"Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78062-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78062-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78062-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T11:05:01Z","timestamp":1730459101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78062-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78062"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78062-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4538996\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TKo has received funding from Torii Pharmaceutical CO., Ltd. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26334"}}